Location: Home
  • search
  • go
  • Relate News
  • 10/8/2018Innovent to Start US Trials of Anti-CD47 Cancer Drug
  • 10/8/2018Genscript Denies Fake Data Allegations after Shares Plunge
  • 10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
  • 10/8/2018Yisheng Biopharma Cleared by NMPA to Proceed with PIKA Rabies Vaccine ...
  • 10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma
  • 10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs
  • 10/8/2018SCMP: Betting Big on Biotech
  • 10/8/2018CANbridge Submits NDA for NERLYNX (neratinib) in China
  • 9/30/2018How Does the Pharma Industry Fit into China's Grand Puzzle of Healthca...
  • 9/30/2018Financial-related Company News in Brief
  • 9/30/2018NMPA Issues Announcement Regarding Direct ADR Reporting by MAHs
  • 9/28/2018Recent Official and Executive Moves
  • 9/28/2018Novartis Enters Deal with CBMG to Make CAR-T Therapy Kymriah
  • 9/27/2018China’s Health Authorities Issue New Rules on Telemedicine
  • 9/27/2018I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics
  • 9/27/2018Alvotech and Changchun HiTech Agree to Codevelop Biosimilars in China
  • 9/27/2018VenatoRx and Everest Medicines Announce License Agreement for Cefepime...
  • 9/27/2018PharmaBlock Acquires Manufacturing Facility in China
  • 9/27/2018The Development of Antibody-drug Conjugates in China
  • 9/26/2018NMPA Restores Import of Cubist Pharma’s Cubicin after Re-inpsection
  • 9/26/2018CDE Seeks Comments on Draft Chinese Translations of ICH Guidelines
  • 9/26/2018Reuters: As China Builds Biotech Sector, Cash Floods U.S. Startups
  • 9/26/2018Shire to Introduce Eight New Rare Disease Therapies in China
  • 9/26/2018Flow Pharma Forms Chinese JV for FlowVax Vaccines
  • 9/25/2018China to Begin Clinical Trials of New HPV Vaccine with Help of Gardasi...
  • 9/25/2018Chinese Pharma Market Primed for Growth after Sweeping Reforms
  • 9/25/2018CSPC Pharma and Verastem Oncology Sign Exclusive License for Anticance...
  • 9/25/2018CDE Issues Notice to “Enhance” GQCE Evaluation of 289 Essential Drug...
  • 9/25/2018AZ and MSD Publish Retail Price of First PARP inhibitor for Ovarian Ca...
  • 9/21/2018NHC Issues Numerous Clinical Guidelines
  • Page:253/720 Total number of articles:21577: [First][<<] [251] [252] [253] [254] [255] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group